Evaluation of chlorprophenpyridamine for prevention of postpartum breast engorgement.
D001941:Breast Diseases; D002744:Chlorpheniramine; D005260:Female; D006634:Histamine H1 Antagonists / Q000628:therapy*; D006801:Humans; D049590:Postpartum Period / Q000150:complications*
D006634:Histamine H1 Antagonists; D002744:Chlorpheniramine
ANTIHISTAMINICS/therapy; BREAST/diseases; PUERPERIUM/complications